Now let me read the calibration papers mentioned by the Human Finder reviewer.Now I have enough to write a thorough, calibrated final review. Let me synthesize the findings.---

## Summary
This paper addresses the underexplored challenge of checkpoint selection during self-supervised learning (SSL) training of vision transformers for histopathology. The authors train nine DINOv1 ViT models of varying scale and architecture on Lung Adenocarcinoma (LUAD) data, and propose a "dual-metric" model selection algorithm (Algorithm 1) that combines task-specific OOD benchmark performance (classification F1, segmentation AJI) with task-agnostic representation quality metrics (RankMe, LiDAR, α-ReQ). Their central empirical finding is that, unlike natural image SSL, the best-performing checkpoints in histopathology consistently occur mid-training rather than at the final epoch, and that small single-tissue DINO models selected by this procedure can achieve segmentation performance competitive with large pan-cancer foundation models (Virchow, Virchow2, UNI).

---

## Strengths

- **Addresses a real and underexplored problem.** Model selection / early stopping for histopathology SSL is a genuine practical challenge that receives far less attention than pretraining architecture or data, and the motivation is well-articulated.

- **Consistent empirical finding across all nine models.** Table 2 uniformly shows that the final-epoch checkpoint never surpasses the selected checkpoints on any model—this finding is demonstrated across architectures (ViT-S, ViT-B, SMoE-4/32/128), data scales (3.27M–10.25M images), and magnifications. This is a robust and practically significant observation.

- **Competitive segmentation performance against large-scale foundation models.** On PanNuke 20× and MoNuSeg, the proposed models frequently match or exceed Virchow, Virchow2, and UNI (Table 2), despite orders-of-magnitude differences in training data. The PanNuke 20× AJI of best proposed models (~0.47–0.48) is competitive with UNI (0.49) and well above Virchow (0.38).

- **Diversity of experimental models and held-out tasks.** Nine architecturally and scale-diverse models, combined with two genuinely held-out downstream tasks (LUAD subtyping, EGFR slide-level classification), lend reasonable credibility to the early-stopping observation.

- **Practical, implementable algorithm with code promise.** The paper commits to releasing code and metric data, and provides a concrete algorithm rather than only qualitative recommendations.

- **Honest acknowledgment of limitations.** Section 6 candidly states that rank estimation approaches "may only predict linear probing performance" and that extending them to non-linear tasks "requires further work," which is scientifically honest.

---

## Weaknesses

### Fatal
*None identified. The paper's core empirical finding (mid-training saturation) is substantiated; the issues below are substantive but not paper-invalidating.*

---

### Major

1. **No ablation of dual-metric vs. benchmark-only selection — the core methodological claim is unvalidated.**
The paper's central contribution is the *dual-metric* combination of task-specific and task-agnostic metrics. Yet there is no condition using only task-specific benchmark metrics (e.g., simply pick the epoch maximizing average AJI/F1), no condition using only rank metrics, and no comparison against a "pick best checkpoint by validation loss" baseline. Without these, it is impossible to know whether the task-agnostic RankMe/LiDAR/α-ReQ terms contribute anything beyond benchmark-only selection. All observed gains are consistent with a simpler story: "monitor benchmark metrics and stop when they peak." This is the central evidential gap of the paper.

2. **The paper's own analysis undermines the role of task-agnostic metrics in Algorithm 1.**
Section 5.1 explicitly states: *"representation ranks are poor indicators of segmentation performance, likely due to the non-linear nature of the task."* Yet Algorithm 1 applies these metrics uniformly across both classification and segmentation selections, with no variant that drops or downweights them for segmentation. The paper does not reconcile this acknowledged inconsistency, and the motivation for including rank metrics in the segmentation-best selection ($e_s^*$) is left unjustified.

3. **"Comparable to state-of-the-art" narrative is selectively presented and overstated for classification tasks.**
The abstract and conclusion emphasize SOTA-comparable performance, but Table 2 shows the proposed models are clearly behind on BACH (best ~0.71 vs. Virchow/UNI 0.76–0.80) and CRC (0.99 vs. 1.00 for all three foundation models). The competitive segmentation numbers are real and notable, but the text glosses over the classification gaps. Furthermore, there is no confirmation that foundation models were evaluated under their optimal native settings (magnification, preprocessing), and the paper provides no error bars to confirm that differences are meaningful.

---

### Minor

4. **Algorithm 1 text/pseudocode mismatch.** Step 5 in Algorithm 1 defines relative improvement as $r_k = \sum_j N^{ts}_{s_k,j}$ (a sum of normalized task-specific scores), while the accompanying text describes it as "using the best benchmark value." These descriptions are not equivalent, and the informal explanation in the body does not match the formal pseudocode. This makes faithful re-implementation difficult.

5. **Held-out downstream task differences are small and inconsistent.** Figure 4 shows that AUC differences between $e_a^*$, $e_c^*$, and $e_s^*$ on LUAD subtyping and EGFR classification are marginal, and no single checkpoint type consistently wins. The claim that task-type-aware selection yields meaningfully different results for held-out tasks is not well supported by these results.

6. **The "longer training is detrimental" claim is presented as domain-general but derived from a narrow setting.** All evidence comes from a single SSL framework (DINOv1), a single tissue type (LUAD), and specific training scales. The paper's phrasing in the abstract and conclusions implies this is a general finding about histopathology SSL, but it is more accurately described as a finding about DINOv1 models on LUAD data. The conclusion should be appropriately scoped.

---

### Trivial

7. **$e_n^*$ notation in Table 2 is confusing.** Multiple rows per model use the same $e_n^*$ notation without clear correspondence to $e_a^*$/$e_c^*$/$e_s^*$ in the text. Minor editorial fix needed.

---

## Nice-to-Haves

- **Ablation with benchmark-only checkpoint selection.** The single most impactful addition. Even a partial ablation on 2–3 models would substantially strengthen the dual-metric claim.
- **Statistical significance or confidence intervals for Figure 4 downstream results.** Given AUC differences of ~0.01–0.02, some indication of variability (bootstrapped CI, multi-run variance) across the 10 train/test splits would clarify whether observed differences are signal or noise. This is not standard practice in all communities, but would genuinely strengthen the held-out task claims.
- **Test on at least one additional SSL framework.** Even a single small DINOv2 or iBOT experiment would help establish whether the early-stopping phenomenon generalizes beyond DINOv1.
- **Representation geometry visualization at different training stages.** t-SNE/UMAP at early, mid, and late training epochs would make the training dynamic concrete and help explain *why* mid-training checkpoints are optimal.
- **Compute cost of the model selection procedure itself.** Running rank metrics and benchmarks across all checkpoints is nontrivial; quantifying this would inform practical adoption.

---

## Removed Points
*These points are flagged to be removed; treat them with caution.*

- **"Algorithm 1 cannot be independently validated" / reproducibility of hyperparameters (Harsh Critic §5).** Per hard rules, concerns about undisclosed hyperparameters in appendices or inability to reproduce training runs are excluded. The appendices are referenced and the authors plan to release code.

- **"Foundation models cited may not be correctly used" / evaluation protocol alignment (Harsh Critic §3).** Per hard rules, questions about the availability or appropriate use of Virchow/Virchow2/UNI are excluded. The paper applies them through its own pipeline to test OOD generalization, which is a legitimate methodology choice.

- **"Representation metrics are not yet released" / doubts about cited baselines.** No such concern was valid — all cited metrics (RankMe, LiDAR, α-ReQ) are established, published methods.

- **Human Finder's weakness about slide-level segmentation tasks being absent.** The paper explicitly scopes to tile-level benchmarks and two held-out slide-level classification tasks. Demanding slide-level segmentation is out-of-scope for what the paper sets out to do.

- **Human Finder's concern about missing other tissue types in the model selection validation.** The paper explicitly scopes to LUAD (§1.3). Criticizing the absence of other tissue types is scope creep, properly a nice-to-have.

- **Demand for theoretical justification for Algorithm 1's normalization/aggregation scheme (Neutral/Spark).** The paper is an empirical systems contribution. Demanding theoretical proofs for a normalization + argmax heuristic is not standard in this field and is moved to nice-to-have.

---

## Novel Insights

The most genuinely novel and practically useful insight is not the dual-metric algorithm per se, but the consistent empirical demonstration—across nine models varying in size by 40×, architecture family, and dataset scale—that DINOv1 histopathology models trained on single-tissue data exhibit a clear mid-training performance peak on OOD benchmarks that diverges from the monotonically decreasing training loss. This has direct practical implications: practitioners using "train to convergence" are likely leaving performance on the table. The secondary insight—that classification-optimal and segmentation-optimal checkpoints diverge temporally (the former occurring later)—is also practically useful, suggesting that task type should inform not only which model is used but *when training should stop*. Both observations are made across a diverse enough model zoo that they merit serious attention, independent of whether the dual-metric algorithm is the best way to identify these checkpoints.

---

## Suggestions

1. **Add a benchmark-only ablation baseline.** Report the benchmark performance obtained by simply selecting the epoch with the highest average task-specific benchmark score across all metrics. This directly tests whether the rank metrics add anything. If they don't, reframe Algorithm 1 as benchmark-guided early stopping and remove the dual-metric framing.

2. **Reconcile the segmentation-rank inconsistency.** If rank metrics are known poor predictors of segmentation performance, either (a) develop or import a better non-linear quality metric, (b) drop rank metrics from the segmentation-best selection, or (c) present a sensitivity analysis showing their effect on $e_s^*$ is small/benign. As-is, the architecture of the algorithm and the paper's own analysis are in tension.

3. **Tighten the "SOTA comparable" framing.** Fairly report where proposed models lag behind (especially BACH classification), and restrict the competitive performance claim to segmentation tasks where the evidence is stronger. 

4. **Scope the "longer training is detrimental" claim appropriately.** Limit this claim to DINOv1 on single-tissue LUAD training in the abstract and conclusions; the paper's own results do not support a broader domain-wide claim.

---

## Score and Decision

**Calibration:**

- **LiDAR (f3g5XpL9Kb, 6/8/6, Accept Spotlight):** Stronger than this paper — clear theoretical motivation, comprehensive ablations validating the metric, demonstrated utility on multiple architectures. Sets the ceiling for related work.
- **JYTQ6ELUVO "Specialized FMs Struggle" (6/6/6/8, Accept Poster):** Comparable level — an empirical observation paper with practical importance but scope limitations and some overstated claims. The finding is valid even where the method has some gaps.
- **ixP76Y33y1 "Intrinsic Dataset Properties" (6/8/8/6, Accept Poster):** Stronger — provides theoretical backing alongside empirics.
- **ViTally Consistent (5/8/5/3, Reject):** Rejected partly for evaluation protocol issues, not primarily for ablation gaps.
- **Masked Mamba (3/3/3/3, Reject):** Clearly weaker — incremental architecture combination with minimal novelty.

**Position:** This paper sits below LiDAR and the intrinsic properties paper due to the core ablation gap, but above Masked Mamba. It is roughly comparable to JYTQ6ELUVO. The primary difference from a poster-level accept is the critical missing ablation that would validate the dual-metric framing — without it, the paper demonstrates a valuable empirical observation but does not establish its central methodological contribution. The finding about mid-training saturation is genuinely useful and consistently demonstrated, but the dual-metric algorithm's superiority over simpler alternatives is undemonstrated.

**Originality:** Moderate — the observation about mid-training saturation in histopathology SSL is new; Algorithm 1 is a reasonable heuristic but lacks validation.  
**Importance:** High — checkpoint selection is a practical bottleneck in histopathology SSL.  
**Support for Claims:** Weak for the dual-metric claim; strong for the early-stopping observation.  
**Experimental Soundness:** Adequate in scope, but the missing ablation is a genuine gap.  
**Clarity:** Good overall; some notation issues in Table 2 and Algorithm 1.  
**Value to community:** Moderate — the empirical observation about mid-training saturation is worth publishing; the algorithm needs more validation.

**Final score: 5.0** — marginally below acceptance threshold. A clear, simple ablation experiment would likely push this to a poster-level accept.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>